The effects of telemedicine on the quality of life of patients with
lung cancer: a systematic review and meta-analysis

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Background and aims:

Lung cancer patients suffer from deterioration in their physical and psychological function, which exerts a negative influence on their quality of life (QOL). Telemedicine has been proven to be an effective intervention for patients with several chronic diseases. The aim of this systematic review and meta-analysis was to investigate the efficacy of telemedicine in improving QOL in lung cancer patients.

Methods:

PubMed, Cochrane Library, EMBASE, Web of Science and Scopus databases were searched for randomized controlled trials that investigated the effectiveness of telemedicine in lung cancer patients. Review Manager 5.3 and Stata 15.1 were used to perform data analysis.

Results:

Our meta-analysis included eight clinical trials with a total of 635 lung cancer patients. The results showed that the telemedicine group had significantly higher QOL than the usual care group [standard mean difference (SMD) 0.96, 95% confidence interval (CI) 0.29–1.63, I ² = 91%]. In addition, the telemedicine group had lower anxiety (SMD −0.44, 95% CI −0.66 to −0.23, I ² = 3%) and depression scores (SMD −0.48, 95% CI −0.91 to −0.05, I ² = 66%) than the usual care group. However, no significant differences were found in fatigue and pain outcomes between the two groups.

Conclusion:

Telemedicine may be an effective method of improving QOL in lung cancer patients and the further development and use of telemedicine care is recommended.

Related collections

Most cited references 38

Record: found
Abstract: found
Article: found

Is Open Access

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

Rui-Mei Feng, Yi-Nan Zong, Su-Mei Cao … (2019)

Cancer is the leading cause of death in China and depicting the cancer pattern of China would provide basic knowhows on how to tackle it more effectively. In this study we have reviewed several reports of cancer burden, including the Global cancer statistics 2018 and Cancer statistics in China, 2015, along with the GLOBCAN 2018 online database, to investigate the differences of cancer patterns between China, the United States (USA) and the United Kingdom (UK). An estimated 4.3 million new cancer cases and 2.9 million new cancer deaths occurred in China in 2018. Compared to the USA and UK, China has lower cancer incidence but a 30% and 40% higher cancer mortality than the UK and USA, among which 36.4% of the cancer-related deaths were from the digestive tract cancers (stomach, liver, and esophagus cancer) and have relatively poorer prognoses. In comparison, the digestive cancer deaths only took up ≤ 5% of the total cancer deaths in either USA or UK. Other reasons for the higher mortality in China may be the low rate of early-stage cancers at diagnosis and non-uniformed clinical cancer treatment strategies performed by different regions. China is undergoing the cancer transition stage where the cancer spectrum is changing from developing country to developed country, with a rapidly increase cancer burden of colorectal, prostate, female breast cancers in addition to a high occurrence of infection-related and digestive cancers. The incidence of westernized lifestyle-related cancers in China (i.e. colorectal cancer, prostate, bladder cancer) has risen but the incidence of the digestive cancers has decreased from 2000 to 2011. An estimated 40% of the risk factors can be attributed to environmental and lifestyle factors either in China or other developed countries. Tobacco smoking is the single most important carcinogenic risk factor in China, contributing to ~ 24.5% of cancers in males. Chronic infection is another important preventable cancer contributor which is responsible for ~ 17% of cancers. Comprehensive prevention and control strategies in China should include effective tobacco-control policy, recommendations for healthier lifestyles, along with enlarging the coverage of effective screening, educating, and vaccination programs to better sensitize greater awareness control to the general public.

0 comments Cited 867 times – based on 0 reviews      Review now

Record: found
Abstract: found
Article: not found

Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients.

Fabrice Denis, Claire Lethrosne, Nicolas Pourel … (2017)

The use of web-based monitoring for lung cancer patients is growing in interest because of promising recent results suggesting improvement in cancer and resource utilization outcomes. It remains an open question whether the overall survival (OS) in these patients could be improved by using a web-mediated follow-up rather than classical scheduled follow-up and imaging.

0 comments Cited 179 times – based on 0 reviews      Review now

Record: found
Abstract: found
Article: not found

Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer.

Matthew Clark, Ping Yang, Jeff A. Sloan … (2017)

Lung cancer is associated with a greater symptom burden than other cancers, yet little is known about the prevalence of emotional problems and how emotional problems may be related to the physical symptom burden and quality of life in newly diagnosed patients with lung cancer. This study aimed to identify the patient and disease characteristics of patients with lung cancer experiencing emotional problems and to examine how emotional problems relate to quality of life and symptom burden.

0 comments Cited 103 times – based on 0 reviews      Review now

All references

Author and article information

Contributors

Lanlan Pang:

ORCID: https://orcid.org/0000-0002-4932-8117

Zefu Liu

Sheng Lin

Zhidong Liu

Hengyu Liu

Zihang Mai

Zhuowei Liu

Chongxiang Chen:

ORCID: https://orcid.org/0000-0002-2079-881X

Qingyu Zhao

Journal

Journal ID (nlm-ta): Ther Adv Chronic Dis

Journal ID (iso-abbrev): Ther Adv Chronic Dis

Journal ID (publisher-id): TAJ

Journal ID (hwp): sptaj

Title: Therapeutic Advances in Chronic Disease

Publisher: SAGE Publications (Sage UK: London, England )

ISSN (Print): 2040-6223

ISSN (Electronic): 2040-6231

Publication date (Electronic): 7 October 2020

Publication date Collection: 2020

Volume: 11

Electronic Location Identifier: 2040622320961597

Affiliations

[1-2040622320961597]Department of Intensive Care Unit, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China

[2-2040622320961597]Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong Province, China

[3-2040622320961597]Department of Urology, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China

[4-2040622320961597]Department of pulmonary and critical care medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China

[5-2040622320961597]Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong Province, China

[6-2040622320961597]Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong Province, China

[7-2040622320961597]Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong Province, China

[8-2040622320961597]Department of Urology, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China

[9-2040622320961597]Department of Intensive Care Unit, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Dongfeng East Road 651, Guangzhou 510060, China

[10-2040622320961597]Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China

[11-2040622320961597]Department of Intensive Care Unit, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou 510060, China

Author notes

[*] 599232426@ 123456qq.com

[*] zhaoqy163@ 123456163.com

[*]

Contributed equally

Author information

Lanlan Pang https://orcid.org/0000-0002-4932-8117

Chongxiang Chen https://orcid.org/0000-0002-2079-881X

Article

Publisher ID: 10.1177_2040622320961597

DOI: 10.1177/2040622320961597

PMC ID: 7549184

PubMed ID: 33101621

SO-VID: 38cb9f67-da4a-4f29-8042-e188b04ef7cd

License:

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ( https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ( https://us.sagepub.com/en-us/nam/open-access-at-sage).

History

Date received : 14 May 2020

Date accepted : 1 September 2020

Custom metadata

cover-date January-December 2020

typesetter ts1

Keywords: lung cancer,quality of life,symptom burden,telemedicine

Data availability:

Keywords: lung cancer, quality of life, symptom burden, telemedicine

Comments

Comment on this article

Cited by 14

See all cited by

Most referenced authors 443

See all reference authors

The effects of telemedicine on the quality of life of patients with lung cancer: a systematic review and meta-analysis

Read this article at